Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
about
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenAntiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCsGender-specific considerations in the antiretroviral management of HIV-infected women.Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.
P2860
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Selection of resistance mutati ...... nt HIV perinatal transmission.
@en
Selection of resistance mutati ...... nt HIV perinatal transmission.
@nl
type
label
Selection of resistance mutati ...... nt HIV perinatal transmission.
@en
Selection of resistance mutati ...... nt HIV perinatal transmission.
@nl
prefLabel
Selection of resistance mutati ...... nt HIV perinatal transmission.
@en
Selection of resistance mutati ...... nt HIV perinatal transmission.
@nl
P2093
P1433
P1476
Selection of resistance mutati ...... nt HIV perinatal transmission.
@en
P2093
Clementina M Galluzzo
Elena Germinario
Francis Mmirro
Lucia Palmisano
Michele Magoni
Pius Okong
Praxedes Kituuka
Roberta Amici
Stefano Vella
P304
P356
10.1097/00002030-200307040-00022
P407
P577
2003-07-01T00:00:00Z